Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yuan-Pin Hung, Pei-Jane Tsai, Yuan-Ti Lee, Hung-Jen Tang, Hsiao-Ju Lin, Hsiu-Chuan Liu, Jen-Chieh Lee, Bo-Yang Tsai, Po-Ren Hsueh & Wen-Chien Ko. (2018) Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan. Infection and Drug Resistance 11, pages 1197-1203.
Read now
Read now
Yun Cai, Nan Bai, Xu Liu, Beibei Liang, Jin Wang & Rui Wang. (2016) Tigecycline: Alone or in combination?. Infectious Diseases 48:7, pages 491-502.
Read now
Read now
Gökhan Metan, Zeynep Türe, Leylagül Kaynar, Elife Berk, Şebnem Gürsoy, Emine Alp, Hüseyin Kılıç & Mustafa Çetin. (2015) Tigecycline for the treatment of Clostridium difficile infection refractory to metronidazole in haematopoietic stem cell transplant recipients. Journal of Chemotherapy 27:6, pages 354-357.
Read now
Read now
Chaitanya Pant, Abhishek Deshpande, Muhammad A. Altaf, Anil Minocha & Thomas J. Sferra. (2013) Clostridium difficile infection in children: a comprehensive review. Current Medical Research and Opinion 29:8, pages 967-984.
Read now
Read now
Matteo Bassetti, Giovanni Villa, Davide Pecori, Alessandra Arzese & Mark Wilcox. (2012) Epidemiology, diagnosis and treatment of Clostridium difficile infection. Expert Review of Anti-infective Therapy 10:12, pages 1405-1423.
Read now
Read now
Articles from other publishers (16)
Jianwei Chen, Yasheng Li, Siqi Wang, Hongfang Zhang, Yujie Du, Qiang Wu & Hong Wang. (2022) Targeting Clostridioides difficile: New uses for old drugs. Drug Discovery Today 27:7, pages 1862-1873.
Crossref
Crossref
Kairav J. Shah, Kartikeya Cherabuddi, Kalynn B. Pressly, Kaitlyn L. Wright & Ashutosh Shukla. (2020) Clostridioides difficile associated peritonitis in peritoneal dialysis patients – a case series based review of an under-recognized entity with therapeutic challenges. BMC Nephrology 21:1.
Crossref
Crossref
Kuan-Sheng Wu, Ling-Shan Syue, Aristine Cheng, Ting-Yu Yen, Hsien-Meng Chen, Yu-Hsin Chiu, Yu-Lung Hsu, Chun-Hsiang Chiu, Ting-Yi Su, Wan-Lin Tsai, Wei-Yu Chen, Chung-Hao Huang, Huei-Min Hung, Ling-Ju Huang, Hong-Jie Kuo, Pei-Chin Lin, Ching-Hsiang Yang, Pi-Lien Hong, Susan Shin-Jung Lee, Yao-Shen Chen, Yung-Ching Liu & Li-Ming Huang. (2020) Recommendations and guidelines for the treatment of Clostridioides difficile infection in Taiwan. Journal of Microbiology, Immunology and Infection 53:2, pages 191-208.
Crossref
Crossref
Massimo Sartelli, Stefano Di Bella, Lynne V. McFarland, Sahil Khanna, Luis Furuya-Kanamori, Nadir Abuzeid, Fikri M. Abu-Zidan, Luca Ansaloni, Goran Augustin, Miklosh Bala, Offir Ben-Ishay, Walter L. Biffl, Stephen M. Brecher, Adrián Camacho-Ortiz, Miguel A. Caínzos, Shirley Chan, Jill R. Cherry-Bukowiec, Jesse Clanton, Federico Coccolini, Maria E. Cocuz, Raul Coimbra, Francesco Cortese, Yunfeng Cui, Jacek Czepiel, Zaza Demetrashvili, Isidoro Di Carlo, Salomone Di Saverio, Irina M. Dumitru, Christian Eckmann, Edward H. Eiland, Joseph D. Forrester, Gustavo P. Fraga, Jean L. Frossard, Donald E. Fry, Rita Galeiras, Wagih Ghnnam, Carlos A. Gomes, Ewen A. Griffiths, Xavier Guirao, Mohamed H. Ahmed, Torsten Herzog, Jae Il Kim, Tariq Iqbal, Arda Isik, Kamal M. F. Itani, Francesco M. Labricciosa, Yeong Y. Lee, Paul Juang, Aleksandar Karamarkovic, Peter K. Kim, Yoram Kluger, Ari Leppaniemi, Varut Lohsiriwat, Gustavo M. Machain, Sanjay Marwah, John E. Mazuski, Gokhan Metan, Ernest E. Moore, Frederick A. Moore, Carlos A. Ordoñez, Leonardo Pagani, Nicola Petrosillo, Francisco Portela, Kemal Rasa, Miran Rems, Boris E. Sakakushev, Helmut Segovia-Lohse, Gabriele Sganga, Vishal G. Shelat, Patrizia Spigaglia, Pierre Tattevin, Cristian Tranà, Libor Urbánek, Jan Ulrych, Pierluigi Viale, Gian L. Baiocchi & Fausto Catena. (2019) 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World Journal of Emergency Surgery 14:1.
Crossref
Crossref
Chaitra ShankarLaura E. B. NabarroShalini AnandanBalaji Veeraraghavan. (2017) Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram–Negative Organisms?. Microbial Drug Resistance 23:4, pages 437-446.
Crossref
Crossref
Zeina Z. Berro, Righab H. Hamdan, Israa H. Dandache, Mohamad N. Saab, Hussein H. Karnib & Mahmoud H. Younes. (2016) Fecal microbiota transplantation for severe clostridium difficile infection after left ventricular assist device implantation: a case control study and concise review on the local and regional therapies. BMC Infectious Diseases 16:1.
Crossref
Crossref
Bhagyashri D. Navalkele & Stephen A. Lerner. (2016) Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI. Open Forum Infectious Diseases 3:2.
Crossref
Crossref
Massimo Sartelli, Mark A. Malangoni, Fikri M. Abu-Zidan, Ewen A. Griffiths, Stefano Di Bella, Lynne V. McFarland, Ian Eltringham, Vishal G. Shelat, George C. Velmahos, Ciarán P. Kelly, Sahil Khanna, Zaid M. Abdelsattar, Layan Alrahmani, Luca Ansaloni, Goran Augustin, Miklosh Bala, Frédéric Barbut, Offir Ben-Ishay, Aneel Bhangu, Walter L. Biffl, Stephen M. Brecher, Adrián Camacho-Ortiz, Miguel A. Caínzos, Laura A. Canterbury, Fausto Catena, Shirley Chan, Jill R. Cherry-Bukowiec, Jesse Clanton, Federico Coccolini, Maria Elena Cocuz, Raul Coimbra, Charles H. Cook, Yunfeng Cui, Jacek Czepiel, Koray Das, Zaza Demetrashvili, Isidoro Di Carlo, Salomone Di Saverio, Irina Magdalena Dumitru, Catherine Eckert, Christian Eckmann, Edward H. Eiland, Mushira Abdulaziz Enani, Mario Faro, Paula Ferrada, Joseph Derek Forrester, Gustavo P. Fraga, Jean Louis Frossard, Rita Galeiras, Wagih Ghnnam, Carlos Augusto Gomes, Venkata Gorrepati, Mohamed Hassan Ahmed, Torsten Herzog, Felicia Humphrey, Jae Il Kim, Arda Isik, Rao Ivatury, Yeong Yeh Lee, Paul Juang, Luis Furuya-Kanamori, Aleksandar Karamarkovic, Peter K Kim, Yoram Kluger, Wen Chien Ko, Francis D. LaBarbera, Jae Gil Lee, Ari Leppaniemi, Varut Lohsiriwat, Sanjay Marwah, John E. Mazuski, Gokhan Metan, Ernest E. Moore, Frederick Alan Moore, Carl Erik Nord, Carlos A. Ordoñez, Gerson Alves Pereira Júnior, Nicola Petrosillo, Francisco Portela, Basant K. Puri, Arnab Ray, Mansoor Raza, Miran Rems, Boris E. Sakakushev, Gabriele Sganga, Patrizia Spigaglia, David B. Stewart, Pierre Tattevin, Jean Francois Timsit, Kathleen B. To, Cristian Tranà, Waldemar Uhl, Libor Urbánek, Harry van Goor, Angela Vassallo, Jean Ralph Zahar, Emanuele Caproli & Pierluigi Viale. (2015) WSES guidelines for management of Clostridium difficile infection in surgical patients. World Journal of Emergency Surgery 10:1.
Crossref
Crossref
S. Di Bella, C. Nisii & N. Petrosillo. (2015) Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature. International Journal of Antimicrobial Agents 46:1, pages 8-12.
Crossref
Crossref
Yuan-Pin Hung, Jen-Chieh Lee, Hsiao-Ju Lin, Hsiao-Chieh Liu, Yi-Hui Wu, Pei-Jane Tsai & Wen-Chien Ko. (2015) Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection. Antibiotics 4:2, pages 216-229.
Crossref
Crossref
Nicholas S. Britt, Molly E. Steed, Emily M. Potter & Lisa A. Clough. (2014) Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection. Infectious Diseases and Therapy 3:2, pages 321-331.
Crossref
Crossref
Alaina S. Ritter & William A. PetriJr.Jr.. (2013) New developments in chemotherapeutic options for Clostridium difficile colitis. Current Opinion in Infectious Diseases 26:5, pages 461-470.
Crossref
Crossref
D. Bossé, C. Lemire, J. Ruel, A. M. Cantin, F. Ménard & L. Valiquette. (2012) Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection. Infection 41:2, pages 579-582.
Crossref
Crossref
A.M. Jones, E.J. Kuijper & M.H. Wilcox. (2013) Clostridium difficile: A European perspective. Journal of Infection 66:2, pages 115-128.
Crossref
Crossref
L. von Müller, A. Halfmann & M Herrmann. (2012) Aktuelle Daten und Trends zur Antibiotikaresistenzentwicklung von Clostridium difficileCurrent data and trends on the development of antibiotic resistance of Clostridium difficile. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 55:11-12, pages 1410-1417.
Crossref
Crossref
Dominador Lao, Tom Chiang & Eric Gomez. (2012)
Refractory
Clostridium difficile
Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin
. Case Reports in Medicine 2012, pages 1-3.
Crossref
Crossref